Risks increased for ischemic heart disease, arrhythmia/cardiac arrest, cardiomyopathy, and new hypertension
Patients with depression only in the prediagnosis period less likely to receive guideline-recommended treatment, have worse survival
Research shows meaningful and sustained clinician- and patient-reported improvements over eight weeks
No adverse effects seen for antidepressant fulfillment; increases were seen in symptom screening
Family-related factors unlikely to entirely explain this risk, authors say
Rate of patients fulfilling criteria for depression was also higher for COVID-19 patients versus controls
For patients with hematologic malignancies, 18, 22, and 22 percent have clinically significant depression, anxiety, PTSD at six months
Within Latinx sample, girls and gender-nonconforming students reported the highest maladjustment
Clinical and cost-effectiveness superior compared with practitioner-supported cognitive behavioral therapy
Physical activity is plausible pathway linking green space to lower risk